Table 2.
Formulation | Components | Category of methylation effect | Mechanism of regulating DNA methylation | Models | Diseases | In vitro/in vivo | Reference |
---|---|---|---|---|---|---|---|
Xuefuzhuyu capsule and Siji Sanhuang capsule | Dang Gui, Sheng Di Huang, Zhi Gan Cao, Tao Ren, Hong Hua, Zhi Qiao, Chi Shao, Chai Hu, Chuan Xiong, Jie Geng, Niu Xi, Da Huang, Huang Qin, Zhi Zi, and Huang Bai | Hypomethylation | DNMTs↓ | ApoE−/− mice fed with HFD | AS | In vivo | [50] |
| |||||||
Zhizi Chuanxiong capsule | Zhi Zi and Chuan Xiong | Hypermethylation and hypomethylation | Rabbit fed with HFD | AS | In vivo | [14] | |
| |||||||
Danhong injection | Dan Shen and Hong Hua | Hypomethylation | DNMT1↓ | ApoE−/− mice fed with HFD | AS | In vivo | [51] |
| |||||||
Danggui Shaoyao powder | Dang Gui, Chi Shao, Fu Ling, Bai Zhu, Ze Xie, and Chuan Xiong | Hypomethylation | DNMT1↓ | ApoE−/− mice fed with HFD | AS | In vivo | [52] |
| |||||||
Pinggan Qianyang Fang | Tian Ma, Gou Teng, Shi Jue Ming, Mu Li, and Niu Xi | Hypermethylation | DNMT1↑ | Angiotensin II-induced vascular smooth muscle cells | Vascular remodeling | In vitro | [53] |
High-fat diet (HFD) and atherosclerosis (AS).